Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer

BACKGROUND & AIMS: Pancreatic ductal adenocarcinoma (PDAC) remains the most aggressive malignancy with the lowest 5-year survival rate of all cancers in part owing to the lack of tumor-specific therapy and the rapid metastatic nature of this cancer. The gastrointestinal peptide gastrin is a trop...

Descripción completa

Detalles Bibliográficos
Autores principales: Burks, Julian, Nadella, Sandeep, Mahmud, Abdullah, Mankongpaisarnrung, Charoen, Wang, Juan, Hahm, Jong-In, Tucker, Robin D., Shivapurkar, Narayan, Stern, Stephan T., Smith, Jill P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008260/
https://www.ncbi.nlm.nih.gov/pubmed/29928669
http://dx.doi.org/10.1016/j.jcmgh.2018.02.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008260/
https://www.ncbi.nlm.nih.gov/pubmed/29928669
http://dx.doi.org/10.1016/j.jcmgh.2018.02.013

Ejemplares similares